Fans who believe in the Super Bowl logo conspiracy theory are probably ... as the Government and You reporter for the Democrat and Chronicle, with a focus on how government actions affect ...

(RTTNews) - The U.S. Food and Drug Administration has approved AstraZeneca Plc. (AZN.L, AZN) and Daiichi Sankyo's (DSKYF.PK) ENHERTU (fam-trastuzumab deruxtecan-nxki) for the treatment of adult ...

AstraZeneca, a global pharmaceutical company focused on developing life changing medicines, has announced a C$820 million (US$570 million) investment in Canada, creating more than 700 new scientific ...

The positive recommendation from NICE for osimertinib was based on results from the ADAURA Phase III trial. In which, adjuvant treatment (after surgery) with osimertinib in patients with stage II ...

Megan Menchaca is a Houston Independent School District reporter for the Houston Chronicle and the co-author of The Report Card. She can be reached at megan.menchaca@houstonchronicle.com.

Many football fans will tune in this weekend to see if the infamous Super Bowl logo conspiracy theory reigns ... and You reporter for the Democrat and Chronicle, with a focus on how government ...

FDA approves AstraZeneca's Datroway, reducing breast cancer progression risk by 37% per TROPION-Breast01 trial results. Datroway's safety profile remains consistent, with 4.2% ILD rate ...

AstraZeneca AZN announced that the FDA has approved its antibody-drug conjugate (ADC), datopotamab deruxtecan (or Dato-DXd), in patients with a certain type of breast cancer. The drug, developed ...

Goldman Sachs analyst Rajan Sharma maintained a Buy rating on AstraZeneca (AZN – Research Report) today and set a price target of £155.58. The company’s shares closed yesterday at p10,794. ...

With these approvals, AstraZeneca works to lead advancements in treating complex and-life threatening cancers and provide patients with more treatment options to them. The revenue of AstraZaneca ...

A targeted cancer therapy from AstraZeneca’s alliance with Daiichi Sankyo is now FDA approved to treat certain cases of advanced breast cancer, giving the British pharmaceutical giant another ...

A next-generation form of chemotherapy from AstraZeneca and Daiichi Sankyo has won Food and Drug Administration authorization for a form of breast cancer, the first U.S. approval for a drug for ...